Effects of salmeterol on pulmonary function of youth exposed to high altitude in early stage 沙美特罗吸入剂对初进高原青年肺功能的影响
Salmeterol and fluticasone propionate powder treatment of bronchial asthma 沙美特罗替卡松粉剂治疗支气管哮喘的疗效观察
Clinical implications of this review are that for patients with asthma that is poorly controlled with moderate doses of inhaled corticosteroids, additional salmeterol can give symptomatic benefit. 该综述与临床的联系在于:对于使用中等剂量吸入激素控制效果欠佳的哮喘患者,加用沙美特罗有助于症状的改善。
The observation of the clinical effect for combination therapy of fluticasone with salmeterol ( seretide) on pediatric asthma 氟替卡松/沙美特罗松联合用药治疗儿童哮喘疗效观察
Effects of Salmeterol and Fluticasone Propionate Inhalation on Pulmonary Function and Airway Inflammation in COPD Patient during Stable Period 吸入沙美特罗氟替卡松对COPD稳定期患者肺功能及气道炎症的影响
The Effect of Salmeterol Xinafoate and Fluticasone Propionate Powder for in Treating Chronic Obstructive Pulmonary Disease 舒利迭在治疗慢性阻塞性肺病中的辅助作用
Comparision of Therapeutic Effects between Tiotropium Bromide and Salmeterol/ Fluticasone Propionate on Stationary Phases of Chronic Obstructive Pulmonary Disease 噻托溴铵与沙美特罗替卡松对慢性阻塞性肺疾病稳定期疗效比较
Modulating effects of combination of salmeterol and flixonase on the expression of interleukin and airway remodeling in asthmatic patients 氟替卡松联合沙美特罗对小儿哮喘血清白介素的表达及气道重塑的调控作用
Conclusion The inhalation of salmeterol for COPD can significantly improve lung function, alleviate clinic symptoms and improve life quality of the patients. 结论对COPD患者给予沙美特罗吸入治疗能明显改善患者肺功能,缓解临床症状和提高生活质量。
Application of asymmetric Henry reaction in the synthesis of ( R)-salmeterol 不对称亨利反应在(R)-沙美特罗合成中的应用
Therapeutic effect of salmeterol/ fluticasone propionate combined with tiotropium bromide therapy for patients with COPD 联合应用沙美特罗/氟替卡松与噻托溴铵对慢性阻塞性肺疾病肺功能的疗效
A study to assess the effects of combining salmeterol/ fluticasone propionate and respiratory exercise on patients with COPD 沙美特罗替卡松联合呼吸操对慢性阻塞性肺疾病患者肺功能的影响
Salmeterol increase risk of death in asthma patients? 沙美特罗会提高哮喘病人的死亡可能性?
Compared with regular salbutamol, regular salmeterol was not associated with a significant increase in fatal or nonfatal serious adverse events in patients not taking inhaled corticosteroids. 对不吸入糖皮质激素的患者来说,规律使用沙美特罗与规律使用沙丁胺醇相比,其致死性及非致死性严重不良事件的发生率并无显著增加。
Study the clinical curative effect and safety of inhaled salmeterol/ fluticasone in curing childhood bronchial asthma 吸入沙美特罗/氟替卡松治疗儿童支气管哮喘临床疗效与骨密度观察
Aim To develop a new synthetic route to salmeterol. 沙美特罗的新合成路线。
Effect of inhaled salmeterol/ fluticasone in the treatment of acute exacerbations of chronic obstructive pulmonary disease 沙美特罗/氟替卡松联合吸入治疗慢性阻塞性肺疾病急性加重期患者的疗效分析
Objective To evaluate the clinical efficacy and safety of combined salmeterol/ fluticasone propionate in treatment of patients with severe persistent asthma. 目的观察联合应用沙美特罗/丙酸氟替卡松对重度哮喘的治疗作用和安全性。
The clinical significance and improvement of salmeterol/ fluticasone propionate to pulmonary function of children with asthma 沙美特罗/丙酸氟替卡松对哮喘儿童肺功能的改善及临床意义
Determination of liposome/ water partition coefficients of salmeterol and budesonide and study on their influencing factors 沙美特罗和布地奈德的脂质体/水分配系数测定及影响因素考察
Conclusion Salmeterol and fluticasone propionate inhalant can improve pulmonary function in COPD patients. 结论沙美特罗替卡松干粉吸入能够改善慢性阻塞性肺疾病的肺功能。
Conclusion: The onset time and level of asthma can be decreased with proper dosage and inhalation method of Salmeterol fluticasone propionate. 结论:沙美特罗替卡松治疗哮喘,只要用量恰当,吸入的方法正确,可以减少哮喘发作的次数和减轻哮喘发作的程度。
Conclusion Combination of salmeterol/ fluticasone propionate possesses the advantage of effectiveness, safety and well tolerance in patients with severe persistent asthma. 结论联合应用沙美特罗/丙酸氟替卡松对重度哮喘患者具有良好的疗效、安全性和耐受性。
Salmeterol vs salbutamol aerosol treatments in 101 asthma patients 沙美特罗和沙丁胺醇气雾剂治疗哮喘患者101例的对比
Effect of inhaled salmeterol/ fluticasone propionate combination on expression of platelet membrane protein molecules in patients with asthma 联合吸入沙美特罗/丙酸氟替卡松对哮喘患者血小板膜蛋白分子表达的影响
Clinical evaluation of efficacy of fluticasone propionate/ salmeterol in treatment of mild to moderate asthma 长期应用丙酸氟替卡松/沙美特罗治疗轻中度哮喘的临床疗效评价
Method: Salmeterol fluticasone propionate inhalation of different dosages was given according to different illness condition of asthma. 方法:按病情轻、中、重度持续不同,分别给予不同剂量沙美特罗替卡松吸入,同时按需使用短效β2受体激动剂吸入,对<7岁的患儿可加用储雾罐。
After Salmeterol/ Fluticasone inhalation treatment, the COPD patients has improved on dyspnoea. 2. 结论:1.经过沙美特罗/氟替卡松的治疗后,COPD患者呼吸困难得到显著改善。